| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/12/2007 | WO2007078154A1 Process for preparing crystalline form a of lansoprazole |
| 07/12/2007 | WO2007077510A2 Muscarinic receptor antagonists |
| 07/12/2007 | WO2007077508A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 07/12/2007 | WO2007077490A2 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/12/2007 | WO2007077201A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | WO2007077005A1 3 , 5-substitγued piperidine compounds as renin inhibitors |
| 07/12/2007 | WO2007076709A1 Tri-substituted 1h-imidazolyl compounds, preparation methods, pharmaceutical compositions and pharmaceutical uses thereof |
| 07/12/2007 | WO2007059257A8 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 07/12/2007 | WO2007056091A3 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof |
| 07/12/2007 | WO2007042321A3 Kinase inhibitors |
| 07/12/2007 | WO2007038459A3 Carboxyamine compounds and their use in the treatment of hdac dependent diseases |
| 07/12/2007 | WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof |
| 07/12/2007 | WO2007031828A3 Therapeutic pyrrolidines |
| 07/12/2007 | WO2007029078A3 Succinimide and glutarimide derivatives as adrenergic receptor antagonists |
| 07/12/2007 | WO2007014008A3 Benzenesulfonamide inhibitor of ccr2 chemokine receptor |
| 07/12/2007 | WO2006123244A3 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 07/12/2007 | WO2006063293A3 THIOUREAS AS FACTOR Xa INHIBITORS |
| 07/12/2007 | US20070161761 Transition metal complex with a 5-membered nitrogen heterocycle ligand (pyrazole); smaller quantities of alumoxane activator; supportable; homo- or copolymerization of alpha-olefins |
| 07/12/2007 | US20070161689 Indoles having anti-diabetic activity |
| 07/12/2007 | US20070161683 Certain chemical entities, compositions, and methods |
| 07/12/2007 | US20070161682 Using 2-(((-4-x, 3,5-dimethylpyridin-2-yl)methylthio)5-methoxy-1H-benzimidazole where x is a leaving group; oxidation using titanium complex catalyst and base |
| 07/12/2007 | US20070161678 Methods for the synthesis of pyridoxamine |
| 07/12/2007 | US20070161677 Bisarylurea derivatives |
| 07/12/2007 | US20070161675 Processes for hydrazine addition to acrylic macromonomers and products therefrom |
| 07/12/2007 | US20070161674 Useful in causing mitotic arrest and cell death; (cis,trans)-1-cyclopentyl-4-phenyl-5-(phenylcarbonyl)(3-piperidyl)phenyl ketone |
| 07/12/2007 | US20070161669 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 07/12/2007 | US20070161664 Therapeutic compounds |
| 07/12/2007 | US20070161651 Tie-2 modulators and methods of use |
| 07/12/2007 | US20070161649 e.g. 6-Methoxy-(4-benzylpiperidinyl)-indole-5-carboxamide-3-glyoxalic acid; antiinflammatory, antiproliferative agent; neurodegenerative diseases |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161643 Pyridin-2-one compounds useful as inhibitors of thrombin |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 07/12/2007 | US20070161637 Substituted pyridin-2-ylamine analogues |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161634 Compounds as CCR5 antagonists |
| 07/12/2007 | US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/12/2007 | US20070161620 Isoquinoline compound and pharmaceutical use thereof |
| 07/12/2007 | US20070161614 Pyridylether derivatives, their preparation and use |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | CA2636264A1 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/12/2007 | CA2635842A1 Prokineticin 1 receptor antagonists |
| 07/12/2007 | CA2635335A1 Muscarinic receptor antagonists |
| 07/12/2007 | CA2634195A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | CA2634037A1 2-amino-5-piperidinylimidazolone compounds and use thereof for .beta.-secretase modulation |
| 07/12/2007 | CA2633624A1 3,5-substituted piperidine compounds as renin inhibitors |
| 07/12/2007 | CA2632694A1 Isoxazolines for controlling invertebrate pests |
| 07/11/2007 | EP1806605A1 Filter and cyanine compound |
| 07/11/2007 | EP1806348A2 Pyrido (2,3-D)Pyrimidines as inhibitors of cellular proliferation |
| 07/11/2007 | EP1806341A2 (+)Phenyl-(4-{4-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-phenyl}-piperidin-1-yl)-acetic acid methyl ester as lipid lowering agent |
| 07/11/2007 | EP1805168A1 Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds |
| 07/11/2007 | EP1805167A2 Novel product, method and intermediates for the preparation of azetidine derivatives |
| 07/11/2007 | EP1805166A1 Quinoline derivatives |
| 07/11/2007 | EP1805165A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 07/11/2007 | EP1805164A2 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 07/11/2007 | EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 07/11/2007 | EP1805147A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 07/11/2007 | EP1805142A2 Novel pyridine compounds, process for their preparation and compositions containing them |
| 07/11/2007 | EP1805141A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 07/11/2007 | EP1804799A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 07/11/2007 | EP1804797A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 07/11/2007 | EP1804796A2 Amino substituted aryloxybenzylpiperidine derivatives |
| 07/11/2007 | EP1804794A2 Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer s disease |
| 07/11/2007 | EP1664024B1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors |
| 07/11/2007 | EP1608646B1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1458706B1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/11/2007 | EP1355886B1 Fused heterocyclic compounds |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997642A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 07/11/2007 | CN1997641A Diarylamine derivatives as calcium channel blockers |
| 07/11/2007 | CN1997640A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 07/11/2007 | CN1997371A Nicotinamide derivatives and their use as therapeutic agents |
| 07/11/2007 | CN1995037A Preparation method of chiral proton pump inhibitor |
| 07/11/2007 | CN1995036A Optical purity alpha-substituted 2-methyl-5-nitro imidazole-1-ethanol derivative |
| 07/11/2007 | CN1995025A Preparation and uses of triaza benzophenone cluster compound |
| 07/11/2007 | CN1995023A Triazole compound oligopolymer with obvious biological activity |
| 07/11/2007 | CN1325492C Beta-isoindigo coloring agent |
| 07/11/2007 | CN1325491C Novel crystals |
| 07/11/2007 | CN1325490C Method for producing highly pure hydroxy indolyl glyoxylic acid amides |
| 07/11/2007 | CN1325489C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 07/11/2007 | CN1325488C Heterocyclic derivatives |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/11/2007 | CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors |
| 07/11/2007 | CN1325472C Phenyl-substituted cyclic enaminones |
| 07/10/2007 | US7241909 useful in treating biological disorders mediated by vitamin D receptors and/or in treating disorders where a rise in serum calcium is undesirable |
| 07/10/2007 | US7241887 3-azabicyclo[3.2.1]octane derivatives |
| 07/10/2007 | US7241799 Analgesics, vision defects, antiepileptic agents, central nervous system disorders, antiinflammatory agents |
| 07/10/2007 | US7241794 Nonnucleoside reverse transcriptase inhibitors |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241787 Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241769 Pyrimidines as PLK inhibitors |
| 07/10/2007 | US7241767 And thiones, 1-substituted with a pyrazolyl(thio)carbonyl group, e.g., 6-Bromo-1-[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]-8-methyl-3-(1-methylethyl)-2,4(1H,3R)-quinazolinedione; especially for use in growing and stored agronomic crops |